105346-60-9

Upstream product

• 105364-70-3 3-(4-ethoxycarbonyloxy-5-oxo-3-phenyl-2,5-dihydro-furan-2-yl)propionic acid 
• 142484-34-2 3-<3-(2,4-dioxooxazolidin-5-yl)-3-phenyloxiranyl>propionic acid methyl ester 
• 105346-32-5 ethyl 3-(4-hydroxy-5-oxo-3-phenyl-2,5-dihydro-2-furyl)propionate 
• 142484-33-1 methyl (4RS)-4-bromo-5-oxo-5-phenylpentanoate 
• 7285-11-2 chloroform methanol 
• 100-39-0 benzyl bromide 
• 6362-58-9 methyl phenylpyruvate 
• 156-06-9 2-oxo-3-(phenyl)propionic acid 
• 105364-65-6 (4R,5S)-5-(3-Benzyloxy-propyl)-2-oxo-4-phenyl-tetrahydro-furan-3-carboxylic acid methyl ester 
• 90055-23-5 5-(3-benzyloxypropyl)-3-hydroxy-4-phenyl-2(5H)-furanone 
• 105364-69-0 Carbonic acid ethyl ester 5-(3-hydroxy-propyl)-2-oxo-4-phenyl-2,5-dihydro-furan-3-yl ester 
• 90055-19-9 (2R,3R)-2-(3-Benzyloxy-propyl)-3-phenyl-oxirane 
• 90055-24-6 3-hydroxy-5-(3-hydroxypropyl)-4-phenyl-2(5H)-furanone 
• 105364-63-4 (E)-(5-(benzyloxy)pent-1-en-1-yl)benzene 

Downstream Products

• 105364-57-6 methyl 3-(4-methoxy-5-oxo-3-phenyl-2,5-dihydro-furan-2-yl)propionate 
• 105364-58-7 3-(4-acetoxy-5-oxo-3-phenyl-2,5-dihydro-furan-2-yl)propionic acid 
• 17920-83-1 5-phenyl-4-pentenoic acid 
• 117085-42-4 3-(4-hydroxy-5-oxo-3-phenyl-2,5-dihydro-2-furyl)propanamide 
• 90055-24-6 3-hydroxy-5-(3-hydroxypropyl)-4-phenyl-2(5H)-furanone 
• 105364-59-8 Acetic acid 5-(3-hydroxy-propyl)-2-oxo-4-phenyl-2,5-dihydro-furan-3-yl ester 
• 105364-61-2 3-acetoxy-5-(3-acetoxypropyl)-4-phenyl-2(5H)-furanone 
• 105364-62-3 Acetic acid 5-(3-methoxycarbonylamino-propyl)-2-oxo-4-phenyl-2,5-dihydro-furan-3-yl ester 

Relevant academic research and scientific papers

Pharmaceutical preparation for prevention and/or treatment for cataract

In order to prevent or treat cataract, present invention features 3(2H)-furanone derivatives having 3(2H)-furanone skeleton as a main structure and/or pharmaceutically acceptable salts thereof, pharmaceutical preparations containing the derivatives and/or

STUCTURE AND SYNTHESIS OF WF 3681, A NOVEL ALDOSE REDUCTASE INHIBITOR

The structure of WF 3681 (1), an aldose reductase inhibitor isolated from a Chaetomella species, has been determined on the basis of its physical and chemical properties and confirmed by a total synthesis.

New furanone derivatives, process for preparation thereof and use thereof

Described are compounds of the formula: STR1 Wherein A is a lower alkylene group; R1 is a carboxy, hydroxy, lower alkoxycarbonyl, lower alkoxycarbonylamino, phenyl(lower)alkyloxy, benzoyloxy or lower alkanoyloxy group; R2 is a hydrog